Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Spatial and single-cell explorations uncover prognostic significance and immunological functions of mitochondrial calcium uniporter in breast cancer

    The mitochondrial calcium uniporter (MCU) is a transmembrane protein facilitating the entry of calcium ions into mitochondria from the cell cytosol. Maintaining calcium balance is crucial for enhancing cellula...

    Chia-Jung Li, Yen-Dun Tony Tzeng, Jui-Hu Hsiao in Cancer Cell International (2024)

  2. No Access

    Chapter and Conference Paper

    The Development of a Portable and Reusable Ketamine Sensor

    Ketamine is a drug used to cause loss of consciousness or anesthesia. In the wrong hands, it can be used to influence judgment and behavior and can put a person at risk for unwanted or dangerous sexual activit...

    Deng-Yun Jheng, Nguyen Van Hieu in 9th International Conference on the Develo… (2024)

  3. Article

    Open Access

    MAP7D3, a novel prognostic marker for triple-negative breast cancer, drives cell invasiveness and cancer-initiating cell properties to promote metastatic progression

    Patients with triple-negative breast cancer (TNBC) tend to develop visceral metastasis within five years, making them the most challenging BC patients to treat. The MAP7 protein family is a group of microtubul...

    Wen-Hung Kuo, Pei-Yi Chu, Chen-Chi Wang, **-Shen Huang, Shih-Hsuan Chan in Biology Direct (2023)

  4. Article

    Open Access

    Multi-omics and experimental analysis unveil theragnostic value and immunological roles of inner membrane mitochondrial protein (IMMT) in breast cancer

    The inner membrane mitochondrial protein (IMMT) is a central unit of the mitochondrial contact site and cristae organizing system (MICOS). While researchers continue to demonstrate the physiological function o...

    Hung-Yu Lin, Hsing-Ju Wu, Pei-Yi Chu in Journal of Translational Medicine (2023)

  5. Article

    Open Access

    PTEN regulates invasiveness in pancreatic neuroendocrine tumors through DUSP19-mediated VEGFR3 dephosphorylation

    Phosphatase and tensin homolog (PTEN) is a tumor suppressor. Low PTEN expression has been observed in pancreatic neuroendocrine tumors (pNETs) and is associated with increased liver metastasis and poor surviva...

    Tsung-Ming Chang, Pei-Yi Chu, Hui-You Lin, Kuo-Wei Huang in Journal of Biomedical Science (2022)

  6. Article

    Open Access

    IFITM3 promotes malignant progression, cancer stemness and chemoresistance of gastric cancer by targeting MET/AKT/FOXO3/c-MYC axis

    Targeting the HGF/MET signaling pathway has been a viable therapeutic strategy for various cancer types due to hyperactivation of HGF/MET axis occurs frequently that leads to detrimental cancer progression and...

    Pei-Yi Chu, Wei-Chieh Huang, Shiao-Lin Tung, Chung-Ying Tsai in Cell & Bioscience (2022)

  7. Article

    Open Access

    Interfering B cell receptor signaling via SHP-1/p-Lyn axis shows therapeutic potential in diffuse large B-cell lymphoma

    Diffuse large B cell lymphoma (DLBCL) is an aggressive and molecularly heterogeneous non-Hodgkin’s lymphoma. The B cell receptor (BCR) signaling pathway in DLBCL emerges as a new drug target. Protein phosphata...

    Ji-Lin Chen, Pei-Yi Chu, Chun-Teng Huang, Tzu-Ting Huang in Molecular Medicine (2022)

  8. Article

    Open Access

    Novel function of THEMIS2 in the enhancement of cancer stemness and chemoresistance by releasing PTP1B from MET

    Triple negative breast cancer (TNBC) possesses poor prognosis mainly due to lack of effective endocrine or targeted therapies, aggressive nature and high rate of chemoresistance. Cancer stem cells (CSCs) are c...

    Wei-Chieh Huang, Jia-Hau Yen, Yu-Wen Sung, Shiao-Lin Tung, Po-Ming Chen in Oncogene (2022)

  9. Article

    Open Access

    Expression pattern and prognostic impact of glycoprotein non-metastatic B (GPNMB) in triple-negative breast cancer

    Glycoprotein non-metastatic B (GPNMB) is a transmembrane protein overexpressed in numerous cancers including triple-negative breast cancers (TNBC). It has been linked to promote cancer aggressiveness and impli...

    Yu-Hsiang Huang, Pei-Yi Chu, Ji-Lin Chen, Chun-Teng Huang in Scientific Reports (2021)

  10. Article

    Open Access

    An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan

    The incidence of neuroendocrine tumors (NETs) has been increasing in recent decades. Previously, we reported the incidence and survival of NETs in Taiwan by analyzing the 1996–2008 data from the Taiwan Cancer ...

    Jeffrey S. Chang, Li-Tzong Chen, Yan-Shen Shan, Pei-Yi Chu in Scientific Reports (2021)

  11. Article

    Open Access

    Expression of HIF-1α and VEGF in feline mammary gland carcinomas: association with pathological characteristics and clinical outcomes

    The microenvironment within solid malignant tumors, including feline mammary gland carcinomas (FMGCs), is commonly hypoxic, possibly due to the lack of functional blood vessels in rapidly proliferating neoplas...

    Bo Chen, Susanne Je-Han Lin, Wen-Ta Li, Hui-Wen Chang in BMC Veterinary Research (2020)

  12. Article

    Open Access

    Canagliflozin inhibits growth of hepatocellular carcinoma via blocking glucose-influx-induced β-catenin activation

    Accelerated glucose metabolism is critical in hepatocarcinogenesis, but the utilities of different glucose transporter inhibitors in treating hepatocellular carcinoma (HCC) remain largely uncharacterized. In t...

    Man-Hsin Hung, Yao-Li Chen, Li-Ju Chen, Pei-Yi Chu, Feng-Shu Hsieh in Cell Death & Disease (2019)

  13. Article

    Open Access

    IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway

    Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death worldwide. The disease recurrent rate is relatively high resulted in poor 5-year survival in advanced HCC. Cancer stem cells (...

    Wei-Chieh Huang, Shiao-Lin Tung, Yao-Li Chen, Po-Ming Chen, Pei-Yi Chu in BMC Cancer (2018)

  14. Article

    Open Access

    LGR5 overexpression confers poor relapse-free survival in breast cancer patients

    Cancer stem cells (CSCs) are believed to promote the malignant transformation of breast cancer via multiple signaling pathways, including the Wnt/β-catenin pathway. Leucine-rich repeat-containing G protein-cou...

    Ming-Feng Hou, Po-Ming Chen, Pei-Yi Chu in BMC Cancer (2018)

  15. No Access

    Article

    Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells

    Triple negative breast cancer (TNBC) is an aggressive cancer for which prognosis remains poor. Combination therapy is a promising strategy for enhancing treatment efficacy. Blockade of STAT3 signaling may enha...

    Chun-Yu Liu, Kuen-Feng Chen, Tzu-I Chao, Pei-Yi Chu in Journal of Molecular Medicine (2017)

  16. Article

    Open Access

    The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells

    Triple-negative breast cancer (TNBC) remains difficult to treat and urgently needs new therapeutic options. Nintedanib, a multikinase inhibitor, has exhibited efficacy in early clinical trials for HER2-negativ...

    Chun-Yu Liu, Tzu-Ting Huang, Pei-Yi Chu in Experimental & Molecular Medicine (2017)

  17. Article

    Open Access

    The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients

    CD133 (prominin-1) is widely believed to be a cancer stem cell marker in various solid tumor types, and CD133 has been correlated with tumor-initiating capacity. Recently, the nuclear location of CD133 express...

    Yao-Li Chen, **-Yi Lin, Ying-Zi Ming, Wei-Chieh Huang, Rong-Fu Chen in BMC Cancer (2017)

  18. Article

    Open Access

    Erratum to: Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells

    Chun-Yu Liu, Ling-Ming Tseng, Jung-Chen Su, Kung-Chi Chang in Breast Cancer Research (2017)

  19. Article

    Open Access

    Disrupting VEGF-A paracrine and autocrine loops by targeting SHP-1 suppresses triple negative breast cancer metastasis

    Patients with triple-negative breast cancer (TNBC) had an increased likelihood of distant recurrence and death, as compared with those with non-TNBC subtype. Regorafenib is a multi-receptor tyrosine kinase (RT...

    Jung-Chen Su, Ai-Chung Mar, Szu-Hsien Wu, Wei-Tien Tai, Pei-Yi Chu in Scientific Reports (2016)

  20. Article

    Open Access

    Changes in DNA methylation are associated with the development of drug resistance in cervical cancer cells

    Changes in DNA methylation are associated with changes in somatic cell fate without the alteration of coding sequences. In addition to its use as a traceable biomarker, reversible DNA methylation could also se...

    Chih-Cheng Chen, Kuan-Der Lee, Mei-Yu Pai, Pei-Yi Chu in Cancer Cell International (2015)

previous disabled Page of 2